Key facts
- This page summarizes Ajay Kumar Dhadha's Form 4 filing for Raphael Pharmaceutical Inc. (RAPH).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Mar 2025, 16:05.
Ajay Kumar Dhadha - 05 Mar 2025 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)
- Reporting relationship
- Director
- Issuer ticker
- RAPH
- Reported as of
- 05 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2025, 16:05:52 UTC
- Prior SEC filing
- 13 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ajay Kumar Dhadha
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ajay Kumar Dhadha filed Form 4 for Raphael Pharmaceutical Inc. (RAPH) on 06 Mar 2025.
Change
- Previous filing in this sequence was filed on 13 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RAPH
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +350,000
- Change %
- +20996%
- Price
- $0.000000
- Shares after
- 351,667
- Date
- 05 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
RAPH
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 403,153
- Date
- 05 Mar 2025
- Ownership
- By Shanti Gems International Investments Ltd.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RAPH
transaction
Derivative
Warrant to purchase Common Stock
Award
- Transaction value
- $0
- Shares
- +250,000
- Change %
- Price
- $0.000000
- Shares after
- 250,000
- Date
- 05 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 250,000
- Exercise price
- $1.00
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
350,000 shares of Common Stock and 250,000 Warrants to purchase shares of Common Stock of the issuer were received as compensation for the reporting person's service as a director and chairman of the Issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 5, 2025. The Warrants are exercisable immediately and will expire on December 31, 2026.